Connection
Lisa Bero to Pandemics
This is a "connection" page, showing publications Lisa Bero has written about Pandemics.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.911 |
|
|
|
-
Bero LA. Producing Independent, Systematic Review Evidence: Cochrane's Response to COVID-19. Am J Public Health. 2020 07; 110(7):952-953.
Score: 0.410
-
Chiu K, Thow AM, Bero L. The tension between national consistency and jurisdictional professional expansion: The case of pharmacist-administered vaccinations. Res Social Adm Pharm. 2022 10; 18(10):3782-3791.
Score: 0.117
-
Chiu K, Thow AM, Bero L. "Never waste a good crisis": Opportunities and constraints from the COVID-19 pandemic on pharmacists' scope of practice. Res Social Adm Pharm. 2022 09; 18(9):3638-3648.
Score: 0.117
-
Bero LA. Improving the Quality of Systematic Reviews in Public Health: Introduction to the Series. Am J Public Health. 2020 11; 110(11):1601-1602.
Score: 0.106
-
Moynihan R, Macdonald H, Bero L, Godlee F. Commercial influence and covid-19. BMJ. 2020 06 24; 369:m2456.
Score: 0.103
-
Pokorny AMJ, Bero LA, Fox P, Karikios DJ, McEwin EJ, Moynihan R, Mintzes B. Interactions between Australian cancer physicians and the pharmaceutical industry: a qualitative study. BMJ Open. 2023 05 26; 13(5):e065719.
Score: 0.032
-
Soares-Weiser K, Lasserson T, Jorgensen KJ, Woloshin S, Bero L, Brown MD, Fischhoff B. Policy makers must act on incomplete evidence in responding to COVID-19. Cochrane Database Syst Rev. 2020 11 20; 11:ED000149.
Score: 0.027